Advertisement
Research Article| Volume 78, ISSUE 6, P432-438, June 2019

Septic shock among patients with systemic lupus erythematosus: Short and long-term outcome. Analysis of a French nationwide database

  • Arthur Mageau
    Correspondence
    Corresponding author at: IAME UMR 1137, Université Paris-Diderot Equipe 5 DeScID, France.
    Affiliations
    APHP Medical and infectious diseases ICU Bichat hospital, F75018 Paris, France

    Département de Médecine Interne, Université Paris-Diderot, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Paris, France

    IAME UMR 1137, Université Paris-Diderot Equipe 5 DeScID, France
    Search for articles by this author
  • Karim Sacré
    Affiliations
    Département de Médecine Interne, Université Paris-Diderot, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Paris, France
    Search for articles by this author
  • Anne Perozziello
    Affiliations
    APHP Medical and infectious diseases ICU Bichat hospital, F75018 Paris, France

    Département de Médecine Interne, Université Paris-Diderot, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Paris, France

    IAME UMR 1137, Université Paris-Diderot Equipe 5 DeScID, France
    Search for articles by this author
  • Stéphane Ruckly
    Affiliations
    APHP Medical and infectious diseases ICU Bichat hospital, F75018 Paris, France

    Département de Médecine Interne, Université Paris-Diderot, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Paris, France

    IAME UMR 1137, Université Paris-Diderot Equipe 5 DeScID, France
    Search for articles by this author
  • Claire Dupuis
    Affiliations
    APHP Medical and infectious diseases ICU Bichat hospital, F75018 Paris, France

    IAME UMR 1137, Université Paris-Diderot Equipe 5 DeScID, France
    Search for articles by this author
  • Lila Bouadma
    Affiliations
    APHP Medical and infectious diseases ICU Bichat hospital, F75018 Paris, France

    IAME UMR 1137, Université Paris-Diderot Equipe 5 DeScID, France
    Search for articles by this author
  • Thomas Papo
    Affiliations
    Département de Médecine Interne, Université Paris-Diderot, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Paris, France
    Search for articles by this author
  • Jean-François Timsit
    Affiliations
    APHP Medical and infectious diseases ICU Bichat hospital, F75018 Paris, France

    IAME UMR 1137, Université Paris-Diderot Equipe 5 DeScID, France
    Search for articles by this author
Published:April 08, 2019DOI:https://doi.org/10.1016/j.jinf.2019.04.005

      Highlights

      • Among 28,522 SLE patients admitted in France between 2010 and 2015, 1068 experienced septic shock.
      • Septic shock was severe with 34.6% of case requiring invasive mechanical ventilation and 32.0% renal replacement therapy.
      • The 1-year mortality rate was 43.4%.
      • An associated Sjögren syndrome was the only specific SLE phenotype associated with mortality (HR 1.392[1.021–1.899]).
      • One-year healthcare use of septic shock survivors was not different from the other ICU survivors when matched on severity.

      Abstract

      Objectives

      We aimed to assess the characteristics, outcomes and costs of septic shock complicating Systemic Lupus Erythematosus (SLE).

      Methods

      Characteristics of SLE patients experiencing a septic shock in France from 2010 to 2015 were analyzed through the French medico-administrative database. Factors associated with the 1-year post-admission mortality were analyzed, the crude 1-year survival of SLE patients experiencing septic shock was compared to those admitted for another reason, and we compared the 1-year outcome associated with SLE septic shock survival to a matched SLE ICU control population.

      Results

      Among 28,522 SLE patients, 1068 experienced septic shock. The 1-year mortality rate was 43.4%. Independently of the severity, an associated Sjögren syndrome was the only specific SLE phenotype associated with mortality (HR 1.392[1.021–1.899]). Within one year, post-septic shock survivors (n = 738) were re-admitted 6.42[17.3] times with total cost of € 14,431[20,444]. Unmatched analysis showed that the outcome of patients admitted in ICU for septic shock was poorer than that of patients admitted in ICU or hospital for another disease. However, 1-year healthcare use of septic shock survivors was not different from the other ICU survivors when matched on severity.

      Conclusions

      Septic shock is a frequent and severe complication among SLE patients even if it is not associated with more healthcare use than another episode of same severity.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ruiz-Irastorza G
        • Olivares N
        • Ruiz-Arruza I
        • Martinez-Berriotxoa A
        • Egurbide M-V
        • Aguirre C
        Predictors of major infections in systemic lupus erythematosus.
        Arthritis Res Ther. 2009; 11: R109https://doi.org/10.1186/ar2764
        • Dumas G
        • Géri G
        • Montlahuc C
        • Chemam S
        • Dangers L
        • Pichereau C
        • et al.
        Outcomes in critically ill patients with systemic rheumatic disease: a multicenter study.
        CHEST. 2015; 148: 927-935https://doi.org/10.1378/chest.14-3098
        • Thomas G
        • Mancini J
        • Jourde-Chiche N
        • Sarlon G
        • Amoura Z
        • Harlé J-R
        • et al.
        Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis.
        Arthritis Rheumatol Hoboken NJ. 2014; 66: 2503-2511https://doi.org/10.1002/art.38731
        • Yurkovich M
        • Vostretsova K
        • Chen W
        • Aviña-Zubieta JA
        Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies.
        Arthritis Care Res. 2014; 66: 608-616https://doi.org/10.1002/acr.22173
        • Jorge April M
        • Lu N
        • Zhang Y
        • Rai SK
        • Choi HK
        Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999–2014).
        Rheumatology. 2018; https://doi.org/10.1093/rheumatology/kex412
        • Prescott Hallie C
        • Angus Derek C
        Enhancing recovery from sepsis: a review.
        JAMA. 2018; 319: 62-75https://doi.org/10.1001/jama.2017.17687
        • Couris Chantal M
        • Polazzi S
        • Olive F
        • Remontet L
        • Bossard N
        • Gomez F
        • et al.
        Breast cancer incidence using administrative data: correction with sensitivity and specificity.
        J Clin Epidemiol. 2009; 62: 660-666https://doi.org/10.1016/j.jclinepi.2008.07.013
        • Chantry Anne A
        • Deneux-Tharaux C
        • Cans C
        • Ego A
        • Quantin C
        • Bouvier-Colle M-H
        • et al.
        Hospital discharge data can be used for monitoring procedures and intensive care related to severe maternal morbidity.
        J Clin Epidemiol. 2011; 64: 1014-1022https://doi.org/10.1016/j.jclinepi.2010.11.015
        • Zahar J-R
        • Timsit J-F
        • Garrouste-Orgeas M
        • Français A
        • Vesin A
        • Vesim A
        • et al.
        Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality.
        Crit Care Med. 2011; 39: 1886-1895https://doi.org/10.1097/CCM.0b013e31821b827c
        • Kaukonen K-M
        • Bailey M
        • Suzuki S
        • Pilcher D
        • Bellomo R
        Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012.
        JAMA. 2014; 311: 1308-1316https://doi.org/10.1001/jama.2014.2637
        • Quenot J-P
        • Binquet C
        • Kara F
        • Martinet O
        • Ganster F
        • Navellou J-C
        • et al.
        The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study.
        Crit Care Lond Engl. 2013; 17: R65https://doi.org/10.1186/cc12598
        • Stoller J
        • Halpin L
        • Weis M
        • Aplin B
        • Qu W
        • Georgescu C
        • et al.
        Epidemiology of severe sepsis: 2008–2012.
        J Crit Care. 2016; 31: 58-62https://doi.org/10.1016/j.jcrc.2015.09.034
        • Adrie C
        • Alberti C
        • Chaix-Couturier C
        • Azoulay É
        • Lassence A
        • Cohen Y
        • et al.
        Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost.
        J Crit Care. 2005; 20: 46-58https://doi.org/10.1016/j.jcrc.2004.10.005
        • Brinkman S
        • de Jonge E
        • Abu-Hanna A
        • Arbous MS
        • de Lange DW
        • de Keizer NF
        Mortality after hospital discharge in ICU patients.
        Crit Care Med. 2013; 41: 1229-1236https://doi.org/10.1097/CCM.0b013e31827ca4e1
        • Jamme M
        • Daviaud F
        • Charpentier J
        • Marin N
        • Thy M
        • Hourmant Y
        • et al.
        Time course of septic shock in immunocompromised and nonimmunocompromised patients.
        Crit Care Med. 2017; 45: 2031-2039https://doi.org/10.1097/CCM.0000000000002722
        • Siripaitoon B
        • Lertwises S
        • Uea-Areewongsa P
        • Khwannimit B
        A study of Thai patients with systemic lupus erythematosus in the medical intensive care unit: epidemiology and predictors of mortality.
        Lupus. 2015; 24: 98-106https://doi.org/10.1177/0961203314548884
        • Han BK
        • Bhatia R
        • Traisak P
        • Hunter K
        • Milcarek B
        • Schorr C
        • et al.
        Clinical presentations and outcomes of systemic lupus erythematosus patients with infection admitted to the intensive care unit.
        Lupus. 2013; 22: 690-696https://doi.org/10.1177/0961203313490240
        • Hsu C-L
        • Chen K-Y
        • Yeh P-S
        • Hsu Y-L
        • Chang H-T
        • Shau W-Y
        • et al.
        Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study.
        Crit Care. 2005; 9: R177-R183https://doi.org/10.1186/cc3481
        • Whitelaw DA
        • Gopal R
        • Freeman V
        Survival of patients with SLE admitted to an intensive care unit-a retrospective study.
        Clin Rheumatol. 2005; 24: 223-227https://doi.org/10.1007/s10067-004-1007-3
        • Feng P-H
        • Lin S-M
        • Yu C-T
        • Yu K-H
        • Huang C-D
        • Tsai Y-H
        • et al.
        Inadequate antimicrobial treatment for nosocomial infection is a mortality risk factor for systemic lupus erythematous patients admitted to intensive care unit.
        Am J Med Sci. 2010; 340: 64-68https://doi.org/10.1097/MAJ.0b013e3181e0ef9b
        • Alzeer AH
        • Arfaj A
        • Al-Basha SJ
        • Alballa S
        • Wakeel J
        • Al-Arfaj H
        • et al.
        Outcome of patients with systemic lupus erythematosus in intensive care unit.
        Lupus. 2004; 13: 537-542https://doi.org/10.1191/0961203304lu1057oa
        • Ansell SM
        • Bedhesi S
        • Ruff B
        • Mahomed AG
        • Richards G
        • Mer M
        • et al.
        Study of critically ill patients with systemic lupus erythematosus.
        Crit Care Med. 1996; 24: 981-984
        • Li T
        • Carls Ginger S
        • Panopalis P
        • Wang S
        • Gibson TB
        • Goetzel RZ
        Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population.
        Arthritis Rheum. 2009; 61: 755-763https://doi.org/10.1002/art.24545
        • Prescott Hallie C
        • Langa Kenneth M
        • Liu V
        • Escobar GJ
        • Iwashyna TJ
        Increased 1-year healthcare use in survivors of severe sepsis.
        Am J Respir Crit Care Med. 2014; 190: 62-69https://doi.org/10.1164/rccm.201403-0471OC
        • Chambers SA
        • Charman SC
        • Rahman A
        • Isenberg DA
        Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality.
        Ann Rheum Dis. 2007; 66: 1173-1177https://doi.org/10.1136/ard.2006.062984
        • Lechtman S
        • Debray M-P
        • Crestani B
        • Bancal C
        • Hourseau M
        • Dossier A
        • et al.
        Cystic lung disease in Sjögren's syndrome: an observational study.
        Jt Bone Spine Rev Rhum. 2017; 84: 317-321https://doi.org/10.1016/j.jbspin.2016.05.019
        • Brito-Zerón P
        • Kostov B
        • Solans R
        • Fraile G
        • Suárez-Cuervo C
        • Casanovas A
        • et al.
        Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients.
        Ann Rheum Dis. 2016; 75: 348-355https://doi.org/10.1136/annrheumdis-2014-206418
        • Rhee C
        • Murphy MV
        • Li L
        • Platt R
        • Klompas M
        Centers for disease control and prevention epicenters program. Comparison of trends in sepsis incidence and coding using administrative claims versus objective clinical data.
        Clin Infect Dis Off Publ Infect Dis Soc Am. 2015; 60: 88-95https://doi.org/10.1093/cid/ciu750
        • Arnaud L
        • Fagot J-P
        • Mathian A
        • Paita M
        • Fagot-Campagna A
        • Amoura Z
        Prevalence and incidence of systemic lupus erythematosus in France: a 2010 nation-wide population-based study.
        Autoimmun Rev. 2014; 13: 1082-1089https://doi.org/10.1016/j.autrev.2014.08.034